[SCHEDULE 13G] enVVeno Medical Corp SEC Filing

Rhea-AI Filing Summary

enVVeno Medical Corporation (NVNO) disclosed that investor Thomas A. Satterfield, Jr. has filed a Schedule 13G reporting beneficial ownership of 1,822,500 shares of common stock, representing 9.0% of the outstanding shares, based on 20,216,176 shares outstanding as of October 28, 2025. Satterfield has sole voting and dispositive power over 165,000 shares and shared voting and dispositive power over 1,657,500 shares.

The filing explains that 400,000 shares are held through Tomsat Investment & Trading Co., Inc., wholly owned by Satterfield, and 1,250,000 shares are held by Caldwell Mill Opportunity Fund, LLC, a fund managed by an entity in which he owns a 50% interest and serves as Chief Investment Manager. He certifies that the securities were not acquired for the purpose of changing or influencing control of enVVeno, indicating a passive investment stance.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

enVVeno Medical Corporation

(Name of Issuer)

Common Stock, $0.00001 par value per share

(Title of Class of Securities)

29415J106

(CUSIP Number)

11/14/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 29415J106

1

Names of Reporting Persons

Thomas A. Satterfield, Jr.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 165,000.00
6	Shared Voting Power 1,657,500.00
7	Sole Dispositive Power 165,000.00
8	Shared Dispositive Power 1,657,500.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,822,500.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: *Based on 20,216,176 shares of common stock of the issuer (the "Common Stock") outstanding as of October 28, 2025, as reported by the issuer in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: enVVeno Medical Corporation
(b)	Address of issuer's principal executive offices: 70 Doppler, Irvine, CA, 92618
Item 2.
(a)	Name of person filing: Thomas A. Satterfield, Jr.
(b)	Address or principal business office or, if none, residence: 15 Colley Cove Drive Gulf Breeze, Florida 32561
(c)	Citizenship: Incorporated by reference from Item 4 of the Cover Page.
(d)	Title of class of securities: Common Stock, $0.00001 par value per share
(e)	CUSIP No.: 29415J106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Incorporated by reference from Item 9 of the Cover Page.
(b)	Percent of class: Incorporated by reference from Item 11 of the Cover Page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Incorporated by reference from Item 5 of the Cover Page.
	(ii) Shared power to vote or to direct the vote: Incorporated by reference from Item 6 of the Cover Page.
	(iii) Sole power to dispose or to direct the disposition of: Incorporated by reference from Item 7 of the Cover Page.
	(iv) Shared power to dispose or to direct the disposition of: Incorporated by reference from Item 8 of the Cover Page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. With respect to the beneficial ownership reported for Thomas A. Satterfield, Jr., 400,000 shares of Common Stock are held by Tomsat Investment & Trading Co., Inc, a corporation wholly owned by Mr. Satterfield and of which he serves as President, and 1,250,000 shares of Common Stock are held by Caldwell Mill Opportunity Fund, LLC, a fund managed by an entity of which Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager. Additionally, Mr. Satterfield has a limited power of attorney for voting and disposition purposes with respect to the following shares of Common Stock: Rebecca A. Satterfield (7,500 shares). Ms. Satterfield has the right to receive or the power to direct the receipt of the proceeds from the sale of her shares.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Thomas A. Satterfield, Jr.

Signature:	/s/ Thomas A. Satterfield, Jr.
Name/Title:	Thomas A. Satterfield, Jr.
Date:	11/19/2025

FAQ

What percentage of enVVeno Medical (NVNO) does Thomas A. Satterfield Jr. own?

According to the Schedule 13G, Thomas A. Satterfield, Jr. beneficially owns 9.0% of enVVeno Medical Corporation's common stock, based on 20,216,176 shares outstanding as of October 28, 2025.

How many NVNO shares does Thomas A. Satterfield Jr. beneficially own?

The filing reports that 1,822,500 shares of enVVeno Medical common stock are beneficially owned by Thomas A. Satterfield, Jr..

Is Thomas A. Satterfield Jr. a passive or active investor in enVVeno Medical (NVNO)?

The certification states that the securities were not acquired and are not held for the purpose of changing or influencing control of enVVeno Medical, indicating a passive investment under Schedule 13G.

How is Thomas A. Satterfield Jr.’s NVNO ownership structured?

The Schedule 13G notes that 400,000 shares are held by Tomsat Investment & Trading Co., Inc. (wholly owned by Satterfield), 1,250,000 shares are held by Caldwell Mill Opportunity Fund, LLC, and he has a limited power of attorney over 7,500 shares held by Rebecca A. Satterfield.

What voting and dispositive powers does Thomas A. Satterfield Jr. have over NVNO shares?

The filing reports sole voting and dispositive power over 165,000 shares and shared voting and dispositive power over 1,657,500 shares of enVVeno Medical common stock.

What share count was used to calculate Thomas A. Satterfield Jr.’s 9.0% NVNO stake?

The 9.0% ownership figure is based on 20,216,176 shares of enVVeno Medical common stock outstanding as of October 28, 2025, as reported in the company’s Form 10-Q.